SMI meeting: innovations in cardiovascular drugs

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.5, 1999-05, pp. : 711-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SMI’s 2nd Annual Superbugs and Superdrugs Conference: Innovations in Anti-Infectives

By Barrett J.F.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1665-1672

Informa Healthcare

Access to resources Recommend Favorite

Discontinued drugs in 2012: cardiovascular drugs

By Zhao Hong-Ping Jiang Hong-Min Xiang Bing-Ren

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1437-1451

Informa Healthcare

Access to resources Recommend Favorite

Discontinued drugs in 2007: cardiovascular drugs

By Xu-song Zhang Bing-ren Xiang

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1817-1828

Informa Healthcare

Access to resources Recommend Favorite

Discontinued drugs in 2011: cardiovascular drugs

By Zhao Hong-Ping Jiang Hong-Min Xiang Bing-Ren

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1449-1462

Informa Healthcare

Access to resources Recommend Favorite

Discontinued drugs in 2010: cardiovascular drugs

By Zhao Hong-ping Zhang Xu-song Xiang Bing-ren

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1311-1325

Informa Healthcare

Access to resources Recommend Favorite